Clinical Trial Update: PK of TAF and TDF for PrEP in Pregnant and Postpartum Women [Phase 3]

View source ↗

Summary

Phase 3 pharmacokinetic study of tenofovir alafenamide and tenofovir disoproxil fumarate for HIV PrEP in pregnant and postpartum women; results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Descovy (emtricitabine/tenofovir alafenamide)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Hiv | Phase 3 | Status: COMPLETED | Results posted: 2024-09-03